These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11555379)

  • 1. Diagnostic utility of CYFRA 21-1 in malignant pleural effusion.
    Dejsomritrutai W; Senawong S; Promkiamon B
    Respirology; 2001 Sep; 6(3):213-6. PubMed ID: 11555379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion.
    Lai RS; Chen CC; Lee PC; Lu JY
    Jpn J Clin Oncol; 1999 Sep; 29(9):421-4. PubMed ID: 10563194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions.
    Romero S; Fernández C; Arriero JM; Espasa A; Candela A; Martín C; Sánchez-Payá J
    Eur Respir J; 1996 Jan; 9(1):17-23. PubMed ID: 8834328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
    Ferrer J; Villarino MA; Encabo G; Felip E; Bermejo B; Vilà S; Orriols R
    Cancer; 1999 Oct; 86(8):1488-95. PubMed ID: 10526277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cytokeratin fragments 19.1 and 19.21 (Cyfra 21-1) in the differentiation of malignant and benign pleural effusions.
    Lee YC; Knox BS; Garrett JE
    Aust N Z J Med; 1999 Dec; 29(6):765-9. PubMed ID: 10677119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
    Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
    Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma.
    Paganuzzi M; Onetto M; Marroni P; Filiberti R; Tassara E; Parodi S; Felletti R
    Chest; 2001 Apr; 119(4):1138-42. PubMed ID: 11296181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions.
    Korczynski P; Krenke R; Safianowska A; Gorska K; Abou Chaz MB; Maskey-Warzechowska M; Kondracka A; Nasilowski J; Chazan R
    Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):128-33. PubMed ID: 20156743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion.
    Chen M; Xie S; Wan C; Zeng N; Wu Y; Qin J; Shen Y; Wen F
    Postgrad Med; 2017 Aug; 129(6):644-648. PubMed ID: 28506100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of tumor markers Cyfra 21-1 and neuron-specific enolase in analysis of pleural fluid.
    Lyubimova NV; Yag'ya TN; Chuchalin AG; Kushlinskii NE
    Bull Exp Biol Med; 2002 May; 133(5):478-80. PubMed ID: 12420066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
    Lee JH; Chang JH
    Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis.
    Gu P; Huang G; Chen Y; Zhu C; Yuan J; Sheng S
    J Clin Lab Anal; 2007; 21(6):398-405. PubMed ID: 18022924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis.
    Szturmowicz M; Tomkowski W; Fijalkowska A; Kupis W; Cieślik A; Demkow U; Langfort R; Wiechecka A; Orlowski T; Torbicki A
    Int J Biol Markers; 2005; 20(1):43-9. PubMed ID: 15832772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of the tumor markers TPA-M, CYPFRA 21-1 and CEA in pleural effusion. Prospective comparison of thoracoscopic investigations in patients with pleural effusion].
    Riedel U; Schönfeld N; Savaser A; Serk M; Loddenkemper R
    Pneumologie; 1999 Oct; 53(10):471-6. PubMed ID: 10596548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
    Salama G; Miédougé M; Rouzaud P; Mauduyt MA; Pujazon MC; Vincent C; Carles P; Serre G
    Br J Cancer; 1998; 77(3):472-6. PubMed ID: 9472646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of CYFRA 21-1 in malignant pleural fluids.
    Satoh H; Sumi M; Yagyu H; Ishikawa H; Suyama T; Naitoh T; Saitoh T; Hasegawa S
    Oncology; 1995; 52(3):211-4. PubMed ID: 7536317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis.
    Liang QL; Shi HZ; Qin XJ; Liang XD; Jiang J; Yang HB
    Thorax; 2008 Jan; 63(1):35-41. PubMed ID: 17573438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma.
    Huang WW; Tsao SM; Lai CL; Su CC; Tseng CE
    Pathology; 2010 Apr; 42(3):224-8. PubMed ID: 20350214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleural CEA, CA-15-3, CYFRA 21-1, CA-19-9, CA-125 discriminating malignant from benign pleural effusions: Diagnostic cancer biomarkers.
    Fazli Khalaf F; Asadi Gharabaghi M; Balibegloo M; Davari H; Afshar S; Jahanbin B
    Int J Biol Markers; 2023 Jun; 38(2):81-88. PubMed ID: 36942429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.